�ؾ���

Dr. Maestri is currently a board certified psychiatric clinical pharmacy specialist (BCPP) serving as a Clinical Assistant Professor at the Xavier University of Louisiana College of Pharmacy.  His area of expertise is the pharmacologic treatment of mental health and substance use disorders. In his role, he provides both experiential and didactic learning opportunities to Xavier Pharmacy students in psychopharmacology, substance use, and ethical principles of pharmacy.  

As part of his practice, he works in collaboration with the LSUHSC psychiatry department at University Medical Center (UMC) to provide optimized care to patients with acute episodes of psychotic, mood, and substance use disorders.  This work is performed in the settings of the inpatient psychiatry units, the behavioral health emergency department, and the psychiatry consult liaison service.

Education:

PGY-2, Psychiatric Pharmacy Residency & Teaching Certificate, 

The University of Texas at Austin/Seton Shoal Creek Hospital - 2016

PGY-1, Pharmacy Practice Residency, Ochsner Medical Center - 2015

Pharm.D., Xavier University of LA College of Pharmacy - 2014

B.S., Chemistry, The University of Southern Mississippi - 2009

Clinical Specialties: 

Board Certified Psychiatric Pharmacy Specialist (BCPP) – 2017

#4150235

Louisiana Pharmacist License – 2014

#PST.020616

Teaching Areas:

PCLN 4778 – Therapeutics III: Psychiatry

PCLN 4640L – Professional Abilities III Lab: Psychiatry

PHAD 5120 – Seminar Pharmacy Ethics

PHSC 3650 – Pharmaceutical Biotechnology and Pharmacogenomics: Psychiatry

Current Research Projects: 

Behavioral Health Integration in the Care of Patients with an Opioid Use Disorder

The Influence of Stress/Trauma and Substance Use on the HIV Prevention and Treatment Continuum

Assessing Mental Health Knowledge Amongst Historically Black College and University (HBCU) Students

Evaluating Community Pharmacists' Stigma and Knowledge Regarding Substance Use Disorders (SUD) Patients and Their Care

A Description of Antipsychotic Prescribing Patterns Based on Race in a Culturally-Diverse Population

Comparison of Time to Readmission between Five Long-acting Injectable Antipsychotics in Acutely Ill Psychiatric Patients

Select Publications: 

Maestri T, Koenig J, Masuda C, Smith T, Garcia-Pittman G. Venous Thromboembolism following Initiation of Atypical Antipsychotics in Two Geriatric Patients. Mental Health Clinician [Internet]. 2017;7(2):1-5.

Maestri T, Mican L, Rozea H, Barner J. Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission? Psychopharmacology Bulletin. 2018;48(3):8-15.